The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Jain Rachit | EVP & CFO | Sell(S) | 875 | $15.60 | $14K |
| Jun 26, 2026 | Friesner Richard | Director | Gift(G) | 679K | — | $0 |
| Jun 26, 2026 | Friesner Richard | Director | Gift(G) | 679K | — | $0 |
| Jun 22, 2026 | Sender Gary | Director | Grant(A) | 8K | — | $0 |
| Jun 22, 2026 | Kapeller-Libermann Rosana | Director | Grant(A) | 8K | — | $0 |
| Jun 22, 2026 | Kapeller-Libermann Rosana | Director | Grant(A) | 13K | — | $0 |
| Jun 22, 2026 | Lynton Michael | Director | Grant(A) | 8K | — | $0 |
| Jun 22, 2026 | Lynton Michael | Director | Grant(A) | 13K | — | $0 |
| Jun 22, 2026 | Thornberry Nancy | Director | Grant(A) | 8K | — | $0 |
| Jun 22, 2026 | Thornberry Nancy | Director | Grant(A) | 13K | — | $0 |
| Jun 22, 2026 | Chodakewitz Jeffrey | Director | Grant(A) | 8K | — | $0 |
| Jun 22, 2026 | Chodakewitz Jeffrey | Director | Grant(A) | 13K | — | $0 |
| Jun 22, 2026 | Friesner Richard | Director | Grant(A) | 8K | — | $0 |
| Jun 22, 2026 | Friesner Richard | Director | Grant(A) | 13K | — | $0 |
| Jun 22, 2026 | Ginsberg Gary L | Director | Grant(A) | 8K | — | $0 |
| Jun 22, 2026 | Ginsberg Gary L | Director | Grant(A) | 13K | — | $0 |
| Jun 22, 2026 | Oberoi Arun | Director | Grant(A) | 8K | — | $0 |
| Jun 22, 2026 | Oberoi Arun | Director | Grant(A) | 13K | — | $0 |
| Jun 22, 2026 | van Kralingen Bridget A | Director | Grant(A) | 8K | — | $0 |
| Jun 22, 2026 | van Kralingen Bridget A | Director | Grant(A) | 13K | — | $0 |
| Jun 22, 2026 | Sender Gary | Director | Grant(A) | 13K | — | $0 |
| Apr 17, 2026 | Farid Ramy | President & CEO, Director | Option exercise(M) | 43K | $3.07 | $132K |
| Apr 17, 2026 | Farid Ramy | President & CEO, Director | Sell(S) | 43K | $12.21 | $525K |
| Apr 17, 2026 | Farid Ramy | President & CEO, Director | Option exercise(M) | 75K | $3.07 | $229K |
| Apr 17, 2026 | Farid Ramy | President & CEO, Director | Option exercise(M) | 43K | — | $0 |
| Apr 17, 2026 | Farid Ramy | President & CEO, Director | Option exercise(M) | 75K | — | $0 |
| Apr 16, 2026 | Farid Ramy | President & CEO, Director | Option exercise(M) | 43K | $3.07 | $132K |
| Apr 16, 2026 | Farid Ramy | President & CEO, Director | Sell(S) | 43K | $12.33 | $530K |
| Apr 16, 2026 | Farid Ramy | President & CEO, Director | Option exercise(M) | 43K | — | $0 |
| Apr 16, 2026 | Jain Rachit | EVP & CFO | Sell(S) | 844 | $12.75 | $11K |
| Mar 6, 2026 | Herman Jenny | CAO | Sell(S) | 608 | $12.84 | $8K |
| Mar 5, 2026 | Akinsanya Karen | See Remarks | Sell(S) | 1K | $12.90 | $18K |
| Mar 5, 2026 | Farid Ramy | President & CEO, Director | Sell(S) | 4K | $12.91 | $47K |
| Mar 5, 2026 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Sell(S) | 1K | $12.90 | $16K |
| Mar 5, 2026 | Tran Yvonne | EVP, CLO & CPO | Sell(S) | 1K | $12.90 | $14K |
| Mar 5, 2026 | Herman Jenny | CAO | Sell(S) | 775 | $12.85 | $10K |
| Mar 5, 2026 | Jain Rachit | EVP & CFO | Sell(S) | 2K | $12.90 | $21K |
| Mar 4, 2026 | Abel Robert Lorne | See Remarks | Sell(S) | 1K | $12.81 | $17K |
| Mar 2, 2026 | Akinsanya Karen | See Remarks | Grant(A) | 24K | — | $0 |
| Mar 2, 2026 | Akinsanya Karen | See Remarks | Sell(S) | 2K | $11.99 | $26K |
| Mar 2, 2026 | Akinsanya Karen | See Remarks | Grant(A) | 28K | — | $0 |
| Mar 2, 2026 | Akinsanya Karen | See Remarks | Grant(A) | 6K | — | $0 |
| Mar 2, 2026 | Akinsanya Karen | See Remarks | Grant(A) | 49K | — | $0 |
| Mar 2, 2026 | Farid Ramy | President & CEO, Director | Grant(A) | 56K | — | $0 |
| Mar 2, 2026 | Farid Ramy | President & CEO, Director | Sell(S) | 6K | $11.90 | $66K |
| Mar 2, 2026 | Farid Ramy | President & CEO, Director | Grant(A) | 48K | — | $0 |
| Mar 2, 2026 | Farid Ramy | President & CEO, Director | Grant(A) | 14K | — | $0 |
| Mar 2, 2026 | Farid Ramy | President & CEO, Director | Grant(A) | 113K | — | $0 |
| Mar 2, 2026 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Grant(A) | 21K | — | $0 |
| Mar 2, 2026 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Grant(A) | 17K | — | $0 |
| Mar 2, 2026 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Grant(A) | 34K | — | $0 |
| Mar 2, 2026 | Tran Yvonne | EVP, CLO & CPO | Grant(A) | 17K | — | $0 |
| Mar 2, 2026 | Tran Yvonne | EVP, CLO & CPO | Grant(A) | 14K | — | $0 |
| Mar 2, 2026 | Tran Yvonne | EVP, CLO & CPO | Grant(A) | 34K | — | $0 |
| Mar 2, 2026 | Herman Jenny | CAO | Grant(A) | 10K | — | $0 |
| Mar 2, 2026 | Herman Jenny | CAO | Grant(A) | 8K | — | $0 |
| Mar 2, 2026 | Abel Robert Lorne | See Remarks | Grant(A) | 17K | — | $0 |
| Mar 2, 2026 | Abel Robert Lorne | See Remarks | Grant(A) | 21K | — | $0 |
| Mar 2, 2026 | Abel Robert Lorne | See Remarks | Grant(A) | 34K | — | $0 |
| Mar 2, 2026 | Friesner Richard | Director | Option exercise(M) | 161K | $3.07 | $493K |
| Mar 2, 2026 | Friesner Richard | Director | Option exercise(M) | 161K | — | $0 |
| Mar 2, 2026 | Aklian Mannix Vartan | See Remarks | Grant(A) | 17K | — | $0 |
| Mar 2, 2026 | Aklian Mannix Vartan | See Remarks | Grant(A) | 34K | — | $0 |
| Mar 2, 2026 | Jain Rachit | EVP & CFO | Grant(A) | 17K | — | $0 |
| Mar 2, 2026 | Jain Rachit | EVP & CFO | Grant(A) | 34K | — | $0 |
| Feb 10, 2026 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Sell(S) | 925 | $13.73 | $13K |
| Feb 10, 2026 | Tran Yvonne | EVP, CLO & CPO | Sell(S) | 776 | $13.80 | $11K |
| Feb 10, 2026 | Herman Jenny | CAO | Sell(S) | 752 | $13.79 | $10K |
| Feb 9, 2026 | Abel Robert Lorne | See Remarks | Sell(S) | 1K | $13.51 | $17K |
| Oct 16, 2025 | Dugan Margaret | Chief Medical Officer | Sell(S) | 1K | $21.07 | $29K |
| Jun 18, 2025 | Friesner Richard | Director | Grant(A) | 6K | — | $0 |
| Jun 18, 2025 | Friesner Richard | Director | Grant(A) | 9K | — | $0 |
| Jun 18, 2025 | Oberoi Arun | Director | Grant(A) | 6K | — | $0 |
| Jun 18, 2025 | Oberoi Arun | Director | Grant(A) | 9K | — | $0 |
| Jun 18, 2025 | Ginsberg Gary L | Director | Grant(A) | 6K | — | $0 |
| Jun 18, 2025 | Ginsberg Gary L | Director | Grant(A) | 9K | — | $0 |
| Jun 18, 2025 | Kapeller-Libermann Rosana | Director | Grant(A) | 6K | — | $0 |
| Jun 18, 2025 | Kapeller-Libermann Rosana | Director | Grant(A) | 9K | — | $0 |
| Jun 18, 2025 | Thornberry Nancy | Director | Grant(A) | 6K | — | $0 |
| Jun 18, 2025 | Thornberry Nancy | Director | Grant(A) | 9K | — | $0 |
| Jun 18, 2025 | van Kralingen Bridget A | Director | Grant(A) | 1K | — | $0 |
| Jun 18, 2025 | van Kralingen Bridget A | Director | Grant(A) | 2K | — | $0 |
| Jun 18, 2025 | Lynton Michael | Director | Grant(A) | 6K | — | $0 |
| Jun 18, 2025 | Lynton Michael | Director | Grant(A) | 9K | — | $0 |
| Jun 18, 2025 | Sender Gary | Director | Grant(A) | 6K | — | $0 |
| Jun 18, 2025 | Sender Gary | Director | Grant(A) | 9K | — | $0 |
| Jun 18, 2025 | Chodakewitz Jeffrey | Director | Grant(A) | 6K | — | $0 |
| Jun 18, 2025 | Chodakewitz Jeffrey | Director | Grant(A) | 9K | — | $0 |
| May 29, 2025 | Aklian Mannix Vartan | See Remarks | Grant(A) | 14K | — | $0 |
| May 29, 2025 | Aklian Mannix Vartan | See Remarks | Grant(A) | 84K | — | $0 |
| May 21, 2025 | Jain Rachit | EVP & CFO | Grant(A) | 9K | — | $0 |
| May 21, 2025 | Jain Rachit | EVP & CFO | Grant(A) | 19K | — | $0 |
| Apr 14, 2025 | Akinsanya Karen | President of R&D, Therapeutics | Sell(S) | 8K | $25.11 | $210K |
| Apr 14, 2025 | Akinsanya Karen | President of R&D, Therapeutics | Option exercise(M) | 13K | $3.22 | $43K |
| Apr 14, 2025 | Akinsanya Karen | President of R&D, Therapeutics | Option exercise(M) | 3K | $2.92 | $10K |
| Apr 14, 2025 | Akinsanya Karen | President of R&D, Therapeutics | Sell(S) | 5K | $25.11 | $126K |
| Apr 14, 2025 | Akinsanya Karen | President of R&D, Therapeutics | Sell(S) | 3K | $25.00 | $84K |
| Apr 14, 2025 | Akinsanya Karen | President of R&D, Therapeutics | Option exercise(M) | 13K | — | $0 |
| Apr 14, 2025 | Akinsanya Karen | President of R&D, Therapeutics | Option exercise(M) | 3K | — | $0 |
| Mar 7, 2025 | van Kralingen Bridget A | Director | Grant(A) | 10K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-08-28. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SDGR